Corcept Therapeutics Incorporated (CORT)
NASDAQ · Healthcare
Corcept Therapeutics Incorporated Operating Income 2009–2025
Corcept Therapeutics Incorporated annual/quarterly operating income history and growth rate from 2009 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Corcept Therapeutics Incorporated operating income for the quarter ending March 31, 2026 was -49.6 M, a 1552.02% decrease year-over-year.
- Corcept Therapeutics Incorporated operating income for the twelve months ending March 31, 2026 was -9.3 M, a 106.50% decrease year-over-year.
- Corcept Therapeutics Incorporated annual operating income for 2025 was 44.8 M, a 67.29% decrease from 2024.
- Corcept Therapeutics Incorporated annual operating income for 2024 was 137.0 M, a 27.66% increase from 2023.
- Corcept Therapeutics Incorporated annual operating income for 2023 was 107.3 M, a 4.75% decrease from 2022.
- Corcept Therapeutics Incorporated annual operating income for 2022 was 112.6 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Corcept Therapeutics Incorporated Operating Income — FAQ
Corcept Therapeutics Incorporated (CORT) operating income over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
What is Corcept Therapeutics Incorporated's operating income?
Corcept Therapeutics Incorporated (CORT) reported operating income of $45M for fiscal 2025.
Where can I see CORT's operating income history?
The chart and table above show Corcept Therapeutics Incorporated's operating income by year and by quarter, including the growth rate.